STRYKER CORP (SYK) Stock Price & Overview
NYSE:SYK • US8636671013
The current stock price of SYK is 365.92 USD. Today SYK is up by 0.37%. In the past month the price increased by 2.13%. In the past year, price decreased by -0.98%.
SYK Key Statistics
- Market Cap
- 140.034B
- P/E
- 26.85
- Fwd P/E
- 24.19
- EPS (TTM)
- 13.63
- Dividend Yield
- 0.95%
SYK Stock Performance
SYK Stock Chart
SYK Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to SYK. When comparing the yearly performance of all stocks, SYK turns out to be only a medium performer in the overall market: it outperformed 43.44% of all stocks.
SYK Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SYK. While SYK belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
SYK Earnings
On January 29, 2026 SYK reported an EPS of 4.47 and a revenue of 7.17B. The company beat EPS expectations (0.69% surprise) and missed revenue expectations (-0.32% surprise).
SYK Forecast & Estimates
37 analysts have analysed SYK and the average price target is 433.16 USD. This implies a price increase of 18.38% is expected in the next year compared to the current price of 365.92.
For the next year, analysts expect an EPS growth of 10.96% and a revenue growth 9.03% for SYK
SYK Groups
Sector & Classification
SYK Financial Highlights
Over the last trailing twelve months SYK reported a non-GAAP Earnings per Share(EPS) of 13.63. The EPS increased by 11.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.92% | ||
| ROA | 6.78% | ||
| ROE | 14.48% | ||
| Debt/Equity | 0.66 |
SYK Ownership
SYK Latest News, Press Relases and Analysis
SYK Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.61 | 190.38B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.29 | 174.071B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.56 | 105.876B | ||
| IDXX | IDEXX LABORATORIES INC | 41.18 | 48.442B | ||
| BDX | BECTON DICKINSON AND CO | 12.14 | 47.586B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.34 | 47.376B | ||
| RMD | RESMED INC | 20.6 | 36.838B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.63 | 33.849B | ||
| DXCM | DEXCOM INC | 27.04 | 26.209B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11 | 18.413B | ||
| HOLX | HOLOGIC INC | 15.4 | 16.908B | ||
| PODD | INSULET CORP | 37.18 | 16.686B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SYK
Company Profile
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 56,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Company Info
STRYKER CORP
1941 Stryker Way
Portage MICHIGAN 49002 US
CEO: Kevin A. Lobo
Employees: 56000
Phone: 12693852600
STRYKER CORP / SYK FAQ
What does STRYKER CORP do?
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 56,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
What is the stock price of STRYKER CORP today?
The current stock price of SYK is 365.92 USD. The price increased by 0.37% in the last trading session.
What is the dividend status of STRYKER CORP?
STRYKER CORP (SYK) has a dividend yield of 0.95%. The yearly dividend amount is currently 3.36.
What is the ChartMill rating of STRYKER CORP stock?
SYK has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Would investing in STRYKER CORP be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SYK.
Is STRYKER CORP (SYK) expected to grow?
The Revenue of STRYKER CORP (SYK) is expected to grow by 9.03% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is STRYKER CORP worth?
STRYKER CORP (SYK) has a market capitalization of 140.03B USD. This makes SYK a Large Cap stock.